Fintel reports that on December 15, 2025, Barclays maintained coverage of Pacific Biosciences of California (NasdaqGS:PACB) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 8.25% ...

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 4.5% in the afternoon session after the stock's positive momentum continued as the company announced advances in its ...

We recently published These 10 Stocks are Winning Big. Pacific Biosciences of California, Inc. (NASDAQ:PACB) is one of the best-performing stocks on Monday. Pacific Biosciences jumped by 6.49 percent ...

Minecraft offers a variety of texture packs catering to different themes, from retro to realistic, allowing players to ...

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) – Cantor Fitzgerald issued their FY2025 EPS estimates for Pacific Biosciences of California in a research report issued on Tuesday, ...

Oene Mark Van, the See Remarks of $PACB ($PACB), sold 34,405 shares of the company on 01-10-2025. We received data on the trade from a recent SEC filing. This was a ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where Pacific Biosciences of California, Inc. (NASDAQ:PACB) stands against ...

Decart, an Israeli AI company that emerged from stealth today with $21 million in funding from Sequoia and Oren Zeev, has released what it’s claiming is the first playable “open-world” AI model.